8:30–8:35 A.M.

WELCOMING REMARKS

Wylie Burke, Roundtable Chair
Professor and Chair, Department of Bioethics and Humanities, University of Washington

 
8:35–8:45 A.M.

CHARGE TO WORKSHOP SPEAKERS AND PARTICIPANTS

Geoffrey Ginsburg
Director, Center for Genomic Medicine, Duke University

 
8:45–10:15 A.M.

CURRENT LANDSCAPE

Session Moderator: Aidan Power, Pfizer Inc.

 
8:45–9:00 A.M.

Current Use of Genetic and Genomic Strategies in Drug Development

Nicholas Davies
Partner, Pharmaceutical and Life Sciences Practice, PwC

 
9:00–9:15 A.M.

Economic Incentives for Genetic and Genomic Strategies

Mark Trusheim
Visiting Scientist and Executive-in-Residence, MIT Sloan School of Management; President, Co-Bio Consulting

 
9:15–9:30 A.M.

Perceived Challenges in Genomic-Based Drug Development

Garret A. FitzGerald
Professor of Medicine and Pharmacology and McNeil Professor in Translational Medicine and Therapeutics; Associate Dean for Translational Research; Chair, Department of Pharmacology; Director, Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement